Loading…
Intravenous HYDROmorphone: Can You Manage the Risk?
In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an...
Saved in:
Published in: | Journal of emergency nursing 2011-07, Vol.37 (4), p.377-380 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473 |
container_end_page | 380 |
container_issue | 4 |
container_start_page | 377 |
container_title | Journal of emergency nursing |
container_volume | 37 |
creator | Paparella, Susan |
description | In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary. |
doi_str_mv | 10.1016/j.jen.2011.03.010 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_876191526</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0099176711001243</els_id><sourcerecordid>876191526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</originalsourceid><addsrcrecordid>eNp9kcFO3DAQQK0KVBbaD-CCIjjQS1KPE9sxHKpqKQWJCgm1B06W7UxK0l1nsRMk_h6vFjgglZMvb5488wjZB1oABfG1L3r0BaMABS0LCvQDmQFnMmdKiC0yo1SpHKSQO2Q3xp5SyiWoj2SHgWC0EjAj5aUfg3lAP0wxu7g9u7leDmF1N3g8yebGZ7fDlP0y3vzFbLzD7KaL_759ItutWUT8_PzukT_nP37PL_Kr65-X8-9XuasEH3OF1LatVcyU3DXc0ZZXjUFbM2UZVsB4LRTyBqWylXVC2NLZxipAxSSrZLlHjjfeVRjuJ4yjXnbR4WJhPKbv6loKUGlfkcgv75JQs5IDMFhLD9-g_TAFn_bQdc3S4QDKBB39DwIOVc0lF2sVbCgXhhgDtnoVuqUJjxqoXgfSvU6B9DqQpqVOgdLMwbN5sktsXideiiTgdANguuxDh0FH16F32HQB3aiboXtH_wQJ-Zzk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1514857567</pqid></control><display><type>article</type><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>ScienceDirect Journals</source><creator>Paparella, Susan</creator><creatorcontrib>Paparella, Susan</creatorcontrib><description>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</description><identifier>ISSN: 0099-1767</identifier><identifier>EISSN: 1527-2966</identifier><identifier>DOI: 10.1016/j.jen.2011.03.010</identifier><identifier>PMID: 21620461</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Acute Pain - drug therapy ; Adult ; Analgesics ; Analgesics, Opioid - poisoning ; Analgesics, Opioid - therapeutic use ; Anesthesia ; Drug dosages ; Drug Overdose ; Emergency Nursing - methods ; Fatal Outcome ; Health facilities ; Heart Arrest - chemically induced ; Hospitals ; Humans ; Hydromorphone ; Hydromorphone - poisoning ; Hydromorphone - therapeutic use ; Injections, Intravenous ; Male ; Medication Errors - prevention & control ; Nursing ; Pain management ; Patients ; Respiratory Insufficiency - chemically induced ; Risk management</subject><ispartof>Journal of emergency nursing, 2011-07, Vol.37 (4), p.377-380</ispartof><rights>2011 Emergency Nurses Association</rights><rights>Copyright Elsevier Limited Jul 2011</rights><rights>Copyright Elsevier Science Ltd. Jul 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</citedby><cites>FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,12846,27924,27925,30999,31000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21620461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paparella, Susan</creatorcontrib><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><title>Journal of emergency nursing</title><addtitle>J Emerg Nurs</addtitle><description>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</description><subject>Acute Pain - drug therapy</subject><subject>Adult</subject><subject>Analgesics</subject><subject>Analgesics, Opioid - poisoning</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Anesthesia</subject><subject>Drug dosages</subject><subject>Drug Overdose</subject><subject>Emergency Nursing - methods</subject><subject>Fatal Outcome</subject><subject>Health facilities</subject><subject>Heart Arrest - chemically induced</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hydromorphone</subject><subject>Hydromorphone - poisoning</subject><subject>Hydromorphone - therapeutic use</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medication Errors - prevention & control</subject><subject>Nursing</subject><subject>Pain management</subject><subject>Patients</subject><subject>Respiratory Insufficiency - chemically induced</subject><subject>Risk management</subject><issn>0099-1767</issn><issn>1527-2966</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><sourceid>ALSLI</sourceid><sourceid>HEHIP</sourceid><sourceid>M2S</sourceid><recordid>eNp9kcFO3DAQQK0KVBbaD-CCIjjQS1KPE9sxHKpqKQWJCgm1B06W7UxK0l1nsRMk_h6vFjgglZMvb5488wjZB1oABfG1L3r0BaMABS0LCvQDmQFnMmdKiC0yo1SpHKSQO2Q3xp5SyiWoj2SHgWC0EjAj5aUfg3lAP0wxu7g9u7leDmF1N3g8yebGZ7fDlP0y3vzFbLzD7KaL_759ItutWUT8_PzukT_nP37PL_Kr65-X8-9XuasEH3OF1LatVcyU3DXc0ZZXjUFbM2UZVsB4LRTyBqWylXVC2NLZxipAxSSrZLlHjjfeVRjuJ4yjXnbR4WJhPKbv6loKUGlfkcgv75JQs5IDMFhLD9-g_TAFn_bQdc3S4QDKBB39DwIOVc0lF2sVbCgXhhgDtnoVuqUJjxqoXgfSvU6B9DqQpqVOgdLMwbN5sktsXideiiTgdANguuxDh0FH16F32HQB3aiboXtH_wQJ-Zzk</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Paparella, Susan</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>Intravenous HYDROmorphone: Can You Manage the Risk?</title><author>Paparella, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Pain - drug therapy</topic><topic>Adult</topic><topic>Analgesics</topic><topic>Analgesics, Opioid - poisoning</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Anesthesia</topic><topic>Drug dosages</topic><topic>Drug Overdose</topic><topic>Emergency Nursing - methods</topic><topic>Fatal Outcome</topic><topic>Health facilities</topic><topic>Heart Arrest - chemically induced</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hydromorphone</topic><topic>Hydromorphone - poisoning</topic><topic>Hydromorphone - therapeutic use</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medication Errors - prevention & control</topic><topic>Nursing</topic><topic>Pain management</topic><topic>Patients</topic><topic>Respiratory Insufficiency - chemically induced</topic><topic>Risk management</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paparella, Susan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Proquest Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of emergency nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paparella, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous HYDROmorphone: Can You Manage the Risk?</atitle><jtitle>Journal of emergency nursing</jtitle><addtitle>J Emerg Nurs</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>37</volume><issue>4</issue><spage>377</spage><epage>380</epage><pages>377-380</pages><issn>0099-1767</issn><eissn>1527-2966</eissn><abstract>In a prospective, randomized, double-blind, clinical trial of 198 adult patients presenting in acute severe pain to an academic medical center, Chang and his team observed significant reluctance from emergency department prescribers and nurses when they were asked to use 7 to 10 mg of morphine as an initial starting dose to treat pain; however, the same health care providers showed no hesitancy when a 1- to 1.5-mg dose of HYDROmorphone was suggested. In another ED study, Chang and colleagues showed that following a 2-mg intravenous dose of HYDROmorphone, clinically significant oxygen desaturation developed in up to one third of adult non-elderly patients in the emergency department who complained of severe acute pain.9 Based on advice from its clinical experts, one drug information resource, Lexi-Comp, revised its drug information for HYDROmorphone in 2002 to suggest that an appropriate starting dose of HYDROmorphone for opioid-naïve patients is 0.2 to 0.6 mg administered intravenously every 2 to 3 hours as needed.\n Based on your findings, mitigate the potential for harm by limiting the strength and volumes of HYDROmorphone available in the emergency department to only those doses that are necessary.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>21620461</pmid><doi>10.1016/j.jen.2011.03.010</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0099-1767 |
ispartof | Journal of emergency nursing, 2011-07, Vol.37 (4), p.377-380 |
issn | 0099-1767 1527-2966 |
language | eng |
recordid | cdi_proquest_miscellaneous_876191526 |
source | Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Journals |
subjects | Acute Pain - drug therapy Adult Analgesics Analgesics, Opioid - poisoning Analgesics, Opioid - therapeutic use Anesthesia Drug dosages Drug Overdose Emergency Nursing - methods Fatal Outcome Health facilities Heart Arrest - chemically induced Hospitals Humans Hydromorphone Hydromorphone - poisoning Hydromorphone - therapeutic use Injections, Intravenous Male Medication Errors - prevention & control Nursing Pain management Patients Respiratory Insufficiency - chemically induced Risk management |
title | Intravenous HYDROmorphone: Can You Manage the Risk? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A57%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20HYDROmorphone:%20Can%20You%20Manage%20the%20Risk?&rft.jtitle=Journal%20of%20emergency%20nursing&rft.au=Paparella,%20Susan&rft.date=2011-07-01&rft.volume=37&rft.issue=4&rft.spage=377&rft.epage=380&rft.pages=377-380&rft.issn=0099-1767&rft.eissn=1527-2966&rft_id=info:doi/10.1016/j.jen.2011.03.010&rft_dat=%3Cproquest_cross%3E876191526%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-9e0bffb92a35cd5c0f54daeb829b2e4125869e5de79b4bc66b3cbdb91e9272473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1514857567&rft_id=info:pmid/21620461&rfr_iscdi=true |